Cargando…

Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients

BACKGROUND: A soluble form of cytotoxic‐T‐lymphocyte‐antigen‐4 (sCTLA‐4) is a prognostic biomarker for several cancers but remains unclear in HCC patients. The aim of study is to evaluate the predictive role of serum sCTLA‐4 levels for tumor recurrence of chronic hepatis C (CHC)‐HCC patients receivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Wei, Jeng, Wen‐Juei, Chen, Wei‐Ting, Lin, Chen‐Chun, Lin, Chun‐Yen, Lin, Shi‐Ming, Sheen, I‐Shyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582685/ https://www.ncbi.nlm.nih.gov/pubmed/35435327 http://dx.doi.org/10.1002/cam4.4760

Ejemplares similares

Percutaneous radiofrequency ablation of tumor feeding artery before target tumor ablation may reduce local tumor progression in hepatocellular carcinoma
por: Cheng, Ya-Ting, et al.
Publicado: (2016)

Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization
por: Lin, Po-Ting, et al.
Publicado: (2022)

Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma
por: Teng, Wei, et al.
Publicado: (2019)

CCL4 is the only predictor for non-responder in GT-1 CHC patients with favorable IL28B genotype when treated with PegIFN/RBV
por: Lin, Chia-Chen, et al.
Publicado: (2017)

Incidence and predictors for abnormal liver function during direct-acting antiviral agents in chronic hepatitis C patients
por: Liu, Yen-Chun, et al.
Publicado: (2020)

Predictors of Mortality Within 6 Weeks After Treatment of Gastric Variceal Bleeding in Cirrhotic Patients
por: Teng, Wei, et al.
Publicado: (2014)

IL28B SNP rs12979860 Is a Critical Predictor for On-Treatment and Sustained Virologic Response in Patients with Hepatitis C Virus Genotype-1 Infection
por: Lin, Chun-Yen, et al.
Publicado: (2011)

None of the Six SNPs of IL28B Could Predict Treatment Responses in Genotype 2 Chronic HCV Infected Patients by Propensity Score Matching Analysis
por: Jeng, Wen-Juei, et al.
Publicado: (2012)

Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis
por: Hsieh, Yi-Chung, et al.
Publicado: (2018)

Increased EMR2 expression on neutrophils correlates with disease severity and predicts overall mortality in cirrhotic patients
por: Huang, Chien-Hao, et al.
Publicado: (2016)

Hepatitis B Co-Infection Has Limited Impact on Liver Stiffness Regression in Chronic Hepatitis C Patients Treated with Direct-Acting Antivirals
por: Hsu, Cheng-Er, et al.
Publicado: (2022)

Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection
por: Sun, Wei-Chi, et al.
Publicado: (2017)

Sonic Hedgehog signaling pathway as a potential target to inhibit the progression of hepatocellular carcinoma
por: Jeng, Kuo-Shyang, et al.
Publicado: (2019)

Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction
por: Hu, Ching-Chih, et al.
Publicado: (2017)

In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival
por: Huang, Chien-Hao, et al.
Publicado: (2019)

The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
por: Xu, Zhentian, et al.
Publicado: (2019)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022)

Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma
por: Huang, Xiaozhun, et al.
Publicado: (2022)

Bronchobiliary fistula after radiofrequency ablation for hepatocellular carcinoma successfully treated by double drainage
por: Chang, Yi Chen, et al.
Publicado: (2018)

Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma
por: Su, Chung‐Wei, et al.
Publicado: (2022)

Radiofrequency Thermal Ablation of Hepatocellular Carcinomas
por: Lim, Hyo Keun
Publicado: (2000)

Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study
por: Chen, Yi-Cheng, et al.
Publicado: (2020)

The Role of Endoglin in Hepatocellular Carcinoma
por: Jeng, Kuo-Shyang, et al.
Publicado: (2021)

Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results
por: Chiang, Pi-Ling, et al.
Publicado: (2023)

Localization Strategy Prior to Radiofrequency Ablation for Primary and Secondary Hyperparathyroidism
por: Lee, Chih-Ying, et al.
Publicado: (2023)

Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
por: Lin, Zhong-Zhe, et al.
Publicado: (2013)

Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer
por: LIU, JING, et al.
Publicado: (2014)

Radiofrequency ablation induces tumor cell dissemination in a mouse model of hepatocellular carcinoma
por: Zhuang, Bowen, et al.
Publicado: (2023)

Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients
por: Teng, Wei, et al.
Publicado: (2021)

Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma
por: Lee, Lu-Hung, et al.
Publicado: (2017)

Laparoscopic hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis
por: Li, Xiaocheng, et al.
Publicado: (2019)

The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus
por: Lin, Chun-Yen, et al.
Publicado: (2021)

A global perspective on hepatitis B‐related single nucleotide polymorphisms and evolution during human migration
por: Tai, Dar‐In, et al.
Publicado: (2017)

Effectiveness and safety of focused ultrasound ablation surgery compared with radiofrequency ablation in primary hepatocellular carcinoma treatment: a meta-analysis
por: Zhang, Jian-Ying, et al.
Publicado: (2021)

Gene and protein expression of a soluble form of CTLA-4 in a healthy dog
por: TAGAWA, Michihito, et al.
Publicado: (2017)

Robot-Assisted Radiofrequency Ablation Combined with Thermodynamic Simulation for Epilepsy Reoperations
por: Wang, Yu-Chi, et al.
Publicado: (2022)

Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma
por: Zhang, Yan-Hua, et al.
Publicado: (2020)

Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis
por: Cheng, Po-Lung, et al.
Publicado: (2023)

Upper Gastrointestinal Cancer and Liver Cirrhosis
por: Jeng, Kuo-Shyang, et al.
Publicado: (2022)

Is the Linear Modeling Technique Good Enough for Optimal Form Design? A Comparison of Quantitative Analysis Models
por: Lin, Yang-Cheng, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rl7seink3mpm5vdoidpvqpk8ci